| 000 | 01861 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513111320.0 | ||
| 264 | 0 | _c19970410 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0148-396X | ||
| 024 | 7 |
_a10.1097/00006123-199702000-00010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aManno, E M | |
| 245 | 0 | 0 |
_aThe safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study. _h[electronic resource] |
| 260 |
_bNeurosurgery _cFeb 1997 |
||
| 300 |
_a289-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAneurysm, Ruptured _xcomplications |
| 650 | 0 | 4 |
_aBlood Flow Velocity _xdrug effects |
| 650 | 0 | 4 | _aCritical Care |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aIntracranial Aneurysm _xcomplications |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeurologic Examination _xdrug effects |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aSubarachnoid Hemorrhage _xclassification |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUltrasonography, Doppler, Transcranial _xdrug effects |
| 700 | 1 | _aGress, D R | |
| 700 | 1 | _aOgilvy, C S | |
| 700 | 1 | _aStone, C M | |
| 700 | 1 | _aZervas, N T | |
| 773 | 0 |
_tNeurosurgery _gvol. 40 _gno. 2 _gp. 289-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006123-199702000-00010 _zAvailable from publisher's website |
| 999 |
_c8998870 _d8998870 |
||